tochondrial structure have been shown in brains from rats, guinea pigs, and newborn rabbits studied by various experimental techniques. Some investigations suggest a primary mitochondrial effect of bilirubin as the etiology of cellular toxicity (I, [8] [9] [10] , while others suggest alternate sites of toxicity (6, II) . Studies in vivo by Diamond and Schmid (6) have particularly emphasized that bilirubin toxicity may involve pathways other than uncoupling of mitochondrial oxidative phosphorylation. They observed ataxia and seizures in young guinea pigs given unconjugated bilirubin, even though normal oxidative phosphorylation was maintained in freshly prepared brain mitochondria from the same animals. More recently, toxic effects ofbilirubin on cerebral glucose metabolism have been suggested by observations in young rats of impaired glycolysis and increased brain glycogen content (4, 5) , and in newborn rabbits of decreased phosphorylation of protein kinase (7) .
Based on these earlier findings in vitro and in vivo, we speculated that bilirubin, when deposited in the brain , may alter rates of cerebral oxygen, glucose, and lactate uptake and consumption. The purpose of this study was to investigate the acute effect of unconjugated bilirubin on in vivo cerebral uptake of oxygen, glucose, and lactate in newborn piglets.
The biochemical mechanism of bilirubin toxicity has been extensively investigated. However, there is no uniformly accepted explanation of its effect. Since the initial report of the inhibition of brain respiration in vitro (I), investigation has been concentrated on the mitochondrial effects of bilirubin. Various mitochondrial preparations and tissue culture techniques have demonstrated in vitro inhibition of cellular respiration, oxidative phosphorylation, glycolysis, protein metabolism, and lipid metabolism by unconjugated bilirubin (2) . Many of these studies used pharmacological concentrations of bilirubin with tissues obtained from adult animals.
In vivo investigations of the biochemical toxicity of bilirubin include studies by Schenker et al. (3) on hepatic enzyme phosphorylation and respiration, and various biochemical (4) (5) (6) (7) and ultrastructural studies (8) (9) (10) (11) of the brain in animal models . Abnormalities in glycolysis, oxidative phosphorylation, and mi-
MATERIALS AND METHODS
An imal preparation. Seventeen newborn piglets, between 2 and 5 days of age, were obtained from a local hog breeder. The piglets remained with the sow until the morning of surgery. Surgery for catheter placement was performed under an infant radiant warmer. Anesthesia consisted of 70% nitrous oxide and 30% oxygen administered via a head hood and local lidocaine (I %) anesthesia. Using sterile techniques, catheters were inserted into I) the left ventricle via the left common carotid, for microsphere injection, 2) the midthoracic aorta via a femoral artery for reference blood sample withdrawal and arterial oxygen content , glucose, and lactate measurements, 3) the superior sagittal sinus for venous oxygen content and glucose and lactate measurements, 4) the contralateral femoral artery for measurement of mean arterial blood pressure, heart rate, and arterial blood gases, and 5) a femoral vein for blood replacement. Placement of the left ventricular catheter was confirmed by pressure tracing and inspection at autopsy. At the conclusion ofsurgery, the piglet received an infusion ofDJOW (5 ml/kg) to prevent hypoglycemia (12) . All blood losses during surgery were replaced with blood from a donor pig less than I month of age. Postoperatively, kanamycin (15 mg/kg) and oxacillin (50 rug/kg) were administered intravenously. The catheters were then filled with heparin (1000 U/ml) and secured in a gauze pouch to the animal.
Once the animal recovered from anesthesia, gavage feeding (30 ml/kg) with an artificial pig milk replacer (Land-Ovl.akes, Co., Minneapolis, MN) was begun and repeated every 4 h. The piglets were allowed an 18-h stabilization period, and were fed I h prior to study.
Experimental protocol. One h prior to study, the piglet was placed in a closed cardboard box to minimize external stimuli, because stimulation has been shown to change cerebral blood flow in piglets (13) . The catheters were exteriorized through a small opening in the box. The study design is shown in Figure   1 .
The subjects were divided into three groups: I) C, (n = 5, weight = 1.29 ± 0.2 kg, mean ± SEM), 2) CS, (n = 5, weight = 1.30 ± 0.2 kg, mean ± SEM), and 3) E, (n = 7, weight 1.31 ± 0.1 kg, mean ± SEM). Following the stabilization period, the C and CS groups received a buffered solution of 18.5% of 0.1 N NaOH , 44.5% of 5% human albumin (Armour Pharmaceutical Company, Kankakee, IL), and 35% of 0.055 M sodium phosphate buffer (Na zHP04, pH = 7.3) by volume. This was administered as a bolus (8 ml/kg) followed by a continuous infusion (6 ml/kg), The E group received a bolus and continuous infusion of the same buffer with 3 mg/ml (0.005 mmol/ml) of bovine bilirubin (Sigma Chemical Corporation, St. Louis, MO). The pH of the buffer and buffer plus bilirubin preparations were adjusted to a physiologic range (pH = 7.44 ± 0.11, mean ± SEM) utilizing a 0.1 N HCl solution . The experimental group received a total bolus of 23 rug/kg (0.039 mmol/kg) and a continuous infusion of 19 mg/kg/h (0.033 mmol/kg/h) of bovine bilirubin. All bilirubin solutions were prepared in a darkened room . During the study period, all buffer or buffer plus bilirubin solutions were shielded from light with aluminum foil. Measurements were made during baseline, and I, 2, 3, and 4 h after the buffer or buffer plus bilirubin bolus. Measurements were made prior to sulfisoxazole boluses in all cases. All animals in the CS and E groups received a total of 0.9 mmol/kg (84 mg/kg) of sulfisoxazole diolamine (Roche Laboratories, Nutley, NJ) in three divided doses at I, 2, and 3 h of study. This dose of sulfisoxazole is known to almost maximally displace bilirubin from its album in binding sites (14) .
At the termination of the study, each piglet was observed for its tone, ability to stand , and ability to walk. Following this, the piglet was anesthetized with nitrous oxide and local infiltration of I% lidocaine. A polyvinyl catheter was then placed in the right carotid artery. The animal was then sacrificed by an overdose of intravenous sodium thiamylal and saturated potassium chloride. To reduce the likelihood of tissue oxidation of bilirubin and to remove the blood from the cerebral vasculature the brain was perfused in situ with cold (4°C) isotonic saline at 60 mm Hg for 15 min (15) .
Immediately after the perfusion, an autopsy was performed on each animal to confirm catheter placement and for removal of the brain, which was separated from the spinal cord at the level of the foramen magnum, divided into right and left hemispheres, and placed in ice. Each hemisphere was weighed; one was used for cerebral blood flow determinations, and the contralateral hemisphere for bilirubin assay. The hemispheres used for the blood flow determinations and measurement ofbilirubin content were alternated between experiments. Each hemisphere was divided into four sections: cerebral cortex, cerebellum, pons/midbrain/medulla, and diencephalon.
M ethodology and analytic methods. Regional brain blood flow was determined by the technique of Heymann et al. (16) with microspheres (15 ± 5 JLm diameter) labeled with 103Ru, S7CO, 113Sn, 46SC, SICr, or 9SNb (New England Nuclear, Boston, MA).
Approximately 6 x 105 microspheres, suspended and continuously agitated in 2 ml of 10% dextran and 0.01% Tween 80, were injected and flushed with 2 ml of normal saline into the left ventricle within 45 s. Reference blood samples were collected continuously for 2 min, beginning 15 s before microsphere injection, and were obtained using a constant withdrawal pump (Harvard Apparatus no. 940, Millis, MA) at a rate of 1.03 ml/ min. In order to maintain a constant hematocrit, blood losses from the study sampling were replaced with blood from a donor piglet less than I month of age. All brain tissue samples were placed in counting vials to a height of I em. The radioactivities of blood and tissue samples were determined in a gamma well counter (Tracor Analytic model 1185, Elk Gro ve Village, IL) connected with a mult ichannel pulse-height analyzer (Canberra model 4203, Meriden, CT). Brain blood flow was calculated with a Digital PdP-I 1/34 computer (Digital Equipment Corp., Maynard, MA) using the equation ( 
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All blood and tissue samples contained sufficient microspheres to ensure a blood flow accuracy to within 10% (16) .
Arterial whole blood pH and blood gas tensions were measured on a Corning 175 blood gas analyzer (Corning Scientific, Medford, MA). Oxygen content was determined in duplicate with the Lex-Os-Con (Lexington Instruments, Waltham, MA). Mean arterial blood pressure and heart rate were measured continuously with a pressure transducer (Hewlett-Packard model 1280c, Waltham , MA) and recorded on a polygraph (Hewlett-Packard model 7754A). Total serum bilirubin was measured by Martinek's modification of the diazo method of Malloy and Evelyn (17) . Serum albumin was determined by a Bromcresol Green assay (18) . The regional brain bilirubin contents were measured with a modified diazo technique after choroform extraction (19) . An enzymatic method was used to determine the serum lactate (20 (22) . To determine the effect of sulfisoxazole on cerebral metabolism, measurements from the two C groups were compared. The effect of bilirubin on cerebral metabolism was analyzed by comparison of the E group and the CS group. All values were expressed as mean ± SEM. Table 1 summarizes the pH , Pa02 , PaC0 2 , base excess, heart rate, mean arterial blood pressure , and hematocrit measurements of the study groups. The arterial pH, Pa02, PaC0 2 , and heart rate values remained unchanged during the studies. Decreases in the mean arterial blood pressure were observed in the control with sulfisoxazole and experimental groups during the studies, but remained within normal limits for newborn piglets. A smaIl but significant decrease in the hematocrit was noted in the CS group at 4 h. There were no changes in arterial oxygen content within the groups and no differences between groups (data not shown) .
The total serum bilirubin levels achieved in the experimental group are shown in Table 2 . These increases were different both from the baseline value in the experimental group and from the CS group at 1, 2, 3, and 4 h. The serum albumin concentration rose from baseline to the end of the study in all groups, because the buffer solution contained 5% human albumin to stabilize the bilirubin solution.
AlI brains from the experimental piglets showed diffuse yelIow staining at autopsy, both superficially and on cut sections. All regions were stained, with slightly deeper staining in the cerebellum and brainstem than in the cerebral hemispheres, as was also noted in a previous study (23) . Grossly, we could not detect discrete staining of the basal ganglia. Histologic examination of these specimens was not done. Table 3 shows the bilirubin content of the frontal and occipital cerebral cortex in the bilirubin-infused group compared with the Heart rate (beats/ C 
DISCUSSION
Minor physiologic changes were observed within the three study groups during the 4-h study period. All bood gas values were within the physiologic range previously reported for newborn piglets (23, 24) . Similarly, the minor reductions in the mean arterial blood pressure were within the normal range previously reported (23, 24) and should not alter cerebral blood flow or metabolism. The slight reductions in hematocrit were because of control groups. Significant amounts of bilirubin were deposited in both areas of the cerebral cortex. Table 4 summarizes the oxygen, glucose, and lactate uptakes, and the blood flow to the cortex of each study group. There were no changes in the cerebral blood flow during the studies in the three groups. A significant decrease in the cerebral oxygen uptake compared with the baseline value was observed at the final study determination in the CS group. The baseline oxygen uptake was slightly higher in this group compared with the other groups, although significant differences among groups were not observed. There were no changes in lactate uptake throughout the study in the three groups and no differences among the groups. The glucose uptake of the CS group increased significantly over baseline at the 3-h measurement. Figure 2 illustrates the significant decreases in the serum arterial glucose concentrations that occurred in all groups over the duration of the study. These decreases were similar among the three groups. Figure 3 illustrates the changes in the cerebral glucose extraction that occurred in the three groups. An increase in extraction was observed at 2, 3, and 4 h in the C group and at 2 and 3 h in the CS group. No significant increase in glucose extraction was noted in the E group.
All piglets that received bilirubin were lethargic and ataxic at the end of the study period, and were unable to stand. In contrast, animals in the C and CS groups were not lethargic and were able to walk.
variations in the hematocrit of the replacement blood and the dilutional effect of the solutions used to flush the catheters. This did not result in significant changes in oxygen carrying capacity in these piglets and did not alter brain blood flow, cerebral oxygen uptake, or extraction.
The superior sagittal sinus is the principal venous drainage for the cerebral cortex. In a steady state, the product of arterialvenous metabolite differences and cerebral cortical blood flow provides a sensitive measurement of cerebral cortical metabolism, and this method is the basis for most in vivo quantitative studies of cerebral substrate utilization (25) .
Measurements of the cerebral consumption of oxygen, glucose, and lactate have been performed in vivo in fetal sheep (26) , infant baboons (27) , and newborn piglets (28) . The cerebral blood flow and rates of consumption of oxygen and glucose in newborn piglets have been previously demonstrated to be similar to those of human infants (13, 28) . Although there is a large discrepancy in the actual brain wight and brain weight-to-body weight ratio between newborn piglets and human infants, the brain of the piglet and human newborn both develop perinatally (29, 30) . As a result of its similarity to the human newborn in brain development, the neonatal pig appears to be a suitable animal model to study the effects of bilirubin on cerebral metabolism.
Even though bilirubin is deposited in even higher concentrations in brain regions other than the cerebral cortex (23) , and many of the abnormal neurologic signs in kernicterus are extrapyramidal, if bilirubin has acute toxic effects on mitochondria it may affect the cerebral cortex as well as other brain regions. In our newborn piglets significant bilirubin deposition was achieved (E group), and therefore acute in vivo alterations in cerebral oxygen, glucose, and lactate uptake should reflect this deposition. The amount of bilirubin given to the piglet by bolus and constant infusion was calculated to equal or exceed the estimated binding capacity of the piglet's albumin. As shown in Table 2 , the serum bilirubin concentration in the E group was approximately equimolar to the albumin concentration between I and 4 h. With a bilirubin load sufficient to bind with an equimolar amount of albumin , the injected concentration of sulfisoxazole (I mM) presumably displaced excess bilirubin from its albumin binding sites, producing cerebral bilirubin concentrations similar to those observed in human infants with kernicterus (31) .
Despite high cerebral bilirubin concentrations (11.0 ± 1.4 nmol/g, mean ± SEM), no acute effects were observed on cerebral utilization of oxygen, glucose, or lactate. However, all of the piglets that received bilirubin infusions were ataxic or lethargic, findings often associated with acute bilirubin encephalopathy in human infants (32) . These abnormal behavioral signs were more likely due to bilirubin toxicity than to reductions in arterial glucose concentrations, because the values observed for arterial glucose concentration remained within the normal range .07 • C, controlgroup, n = 5 unless otherwisenoted in parentheses; CS, controlgroup withsulfisoxazole, n = 5 unless otherwise noted in parentheses; E, experimental group, n = 7 unless otherwise noted in parentheses; NO, not done. t p < 0.05 compared to baseline. than in our C groups. Glucose uptake across the blood-brain barrier is by a facilitated transport mechanism, for which the rate-limiting step is the phosphorylation of glucose to glucose-6-phosphate by the enzyme hexokinase (33) . If bilirubin inhibits glucose transport, it may do so at the hexokinase step, since bilirubin has recently been shown to decrease cerebral protein phosphorylation (7) . We speculate that this mechanism may be involved in the lack of increase in glucose extraction observed in our hyperbilirubinemic, experimental piglets. However, even the finding of blunted glucose extraction in the E group does not support the interpretation that inhibition of mitochondrial metabolism is the primary effect ofbilirubin toxicity in vitro. Despite a smaller increase in the fractional cerebral extraction of glucose for the hyperbilirubinemic E group , the overall rates of glucose previously reported in piglets (13) . Both control groups responded to the slight decreases in serum glucose with an increase in glucose extraction, so that glucose, oxygen, and lactate uptakes remained normal.
The lack of significant change in oxygen, lactate, and glucose uptakes in the E group suggests that the acute biochemical effect of bilirubin is probably not mitochondrial. This hypothesis is supported histochemically by the study of Chen et al. (II) who demonstrated that bilirubin is first deposited in the dendrites and axons of neurons, rather than in the mitochondria. Although Day (I) demonstrated inhibition of mitochondrial respiration in vitro, Diamond and Schmid (6) were unable to demonstrate uncoupling or inhibition of oxidative phosphorylation in a group of hyperbilirubinemic, lethargic guinea pigs. In their studies, bilirubin contents of 17.8 nrnol/g of brain were obtained after I h of exposure, compared to regional brain bilirubin contents of 11.0 nmol/g in our studies. Our findings are therefore consistent with those of Diamond and Schmid (6) , that bilirubin intoxicated experimental animals become lethargic and ataxic despite a lack of measurable changes in glucose oxidation by the brain.
Although remaining within the range of values found in normal piglets by Wootton et al. (13) and in control piglets for this study , both the decrease in serum glucose and the increase in glucose extraction were smaller in our bilirubin-infused group and oxygen uptake and consumption were similar in all three study groups. The finding that marked neurological and behavioral changes were unaccompanied by comparably large changes in cortical oxygen and glucose consumption supports the conclusion, instead, that the toxic effects of bilirubin noted in this study may involve more peripheral, or at least subcortical, mechanisms rather than marked changes in cortical oxidative metabolism . Sulfonamides have various neurologic side effects (34) , and inhibit carbonic anh ydrase (35) , an enzyme present in the choroid plexus. Although sulfisoxazole is distributed almost entirely extracellularly (36) , it was possible that sulfisoxazole alone would affect cerebral metabolism. To exclude this possibility, control groups were studied, with and without sulfisoxazole. Our results demonstrate no effect of sulfisoxazole on cerebral consumption of oxygen, glucose, or lactate.
Early, and possibly reversible, signs of bilirubin intoxication may not be associated with irreversible changes in mitochondrial oxidative phosphorylation . Our findings do not document a marked change in cortical glucose uptake or lactate production, and the earlier findings of Diamond and Schmid (6) also failed to demonstrate marked changes in brain oxidative phosphorylation in living guinea pigs at similar brain bilirubin concentrations. Early findings consistent with bilirubin toxicity may represent the interference of bilirubin with nerve transmission or conduction. This mechanism would be consistent with the anatomical observations of Chen et al. (11) , that the initial locus of bilirubin uptake is in the peripheral part of the nerve cell and in astroglia, rather than in nerve cell bodies. The recent report of Hansen et al. (37) , that bilirubin inhibits phosphorylation of Synapsin I in presynaptic vesicles, is also consistent with the hypothesis that impairment of peripheral nerve transmission may occur in the early stages of acute bilirubin toxicity. Irreversible unco upling of oxidative phosphorylation might represent a later stage of bilirubin toxicity, or a form of toxicity caused by higher local bilirubin concentrations at longer times of exposure.
